126 related articles for article (PubMed ID: 10471042)
21. A role for Octamer binding protein motifs in the regulation of the proximal preprotachykinin-A promoter.
Fiskerstrand CE; Newey P; McGregor GP; Gerrard L; Millan F; Quinn JP
Neuropeptides; 2000 Dec; 34(6):348-54. PubMed ID: 11162291
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of the LAMB3 and LAMC2 genes between small cell and non-small cell lung carcinomas.
Manda R; Kohno T; Niki T; Yamada T; Takenoshita S; Kuwano H; Yokota J
Biochem Biophys Res Commun; 2000 Aug; 275(2):440-5. PubMed ID: 10964684
[TBL] [Abstract][Full Text] [Related]
23. Involvement of a cis-acting element in the suppression of carbamoyl phosphate synthetase I gene expression in the liver of carnitine-deficient mice.
Abdullah Abu Musa DM; Kobayashi K; Yasuda I; Iijima M; Christoffels VM; Tomomura M; Horiuchi M; Ohnishi T; Kajihara T; Daikuhara Y; Lamers WH; Saheki T
Mol Genet Metab; 1999 Nov; 68(3):346-56. PubMed ID: 10562461
[TBL] [Abstract][Full Text] [Related]
24. Difference in responsiveness of human esophageal squamous cell carcinoma lines to epidermal growth factor for MMP-7 expression.
Xu H; Tanimoto A; Murata Y; Kimura S; Wang KY; Sasaguri Y
Int J Oncol; 2003 Aug; 23(2):469-76. PubMed ID: 12851697
[TBL] [Abstract][Full Text] [Related]
25. Regulation of interleukin 2 gene expression: discrepancy between enhancer activity and endogenous gene expression.
Mårtensson IL; Leanderson T
Eur J Immunol; 1989 Jan; 19(1):145-9. PubMed ID: 2537733
[TBL] [Abstract][Full Text] [Related]
26. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
[TBL] [Abstract][Full Text] [Related]
27. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis.
Ocejo-Garcia M; Baokbah TA; Ashurst HL; Cowlishaw D; Soomro I; Coulson JM; Woll PJ
J Pathol; 2005 Jun; 206(2):151-9. PubMed ID: 15856526
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F
Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521
[TBL] [Abstract][Full Text] [Related]
29. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
30. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
Mårtensson UE; Bristulf J; Owman C; Olde B
Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
[TBL] [Abstract][Full Text] [Related]
31. Functional analysis of the 5'-flanking region of the human gastrin-releasing peptide gene in small cell lung carcinoma cell lines.
Nagalla SR; Spindel ER
Cancer Res; 1994 Aug; 54(16):4461-7. PubMed ID: 8044796
[TBL] [Abstract][Full Text] [Related]
32. Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.
Konduri SD; Osman FA; Rao CN; Srinivas H; Yanamandra N; Tasiou A; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Kouraklis G; Rao JS
Oncogene; 2002 Jan; 21(6):921-8. PubMed ID: 11840337
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
34. Oxytocin receptor pattern of expression in primary lung cancer and in normal human lung.
Péqueux C; Breton C; Hagelstein MT; Geenen V; Legros JJ
Lung Cancer; 2005 Nov; 50(2):177-88. PubMed ID: 16043261
[TBL] [Abstract][Full Text] [Related]
35. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
36. Sequence of the 5'-flanking region and promoter activity of the human mucin gene MUC5B in different phenotypes of colon cancer cells.
Van Seuningen I; Perrais M; Pigny P; Porchet N; Aubert JP
Biochem J; 2000 Jun; 348 Pt 3(Pt 3):675-86. PubMed ID: 10840001
[TBL] [Abstract][Full Text] [Related]
37. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
El-Khoury V; Breuzard G; Fourré N; Dufer J
Br J Cancer; 2007 Aug; 97(4):562-73. PubMed ID: 17667922
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
39. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM; Providence KM; Higgins PJ
Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
[TBL] [Abstract][Full Text] [Related]
40. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H
Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
